Back to Search
Start Over
Epigenome-wide association study of adiposity and future risk of obesity-related diseases
- Source :
- International Journal of Obesity, 42(12), 2022-2035. Nature Publishing Group, International Journal of Obesity, 42(12), 2022. Nature Publishing Group
- Publication Year :
- 2018
-
Abstract
- BackgroundObesity is an established risk factor for several common chronic diseases such as breast and colorectal cancer, metabolic and cardiovascular diseases; however, the biological basis for these relationships is not fully understood. To explore the association of obesity with these conditions, we investigated peripheral blood leucocyte (PBL) DNA methylation markers for adiposity and their contribution to risk of incident breast and colorectal cancer and myocardial infarction.MethodsDNA methylation profiles (Illumina Infinium® HumanMethylation450 BeadChip) from 1941 individuals from four population-based European cohorts were analysed in relation to body mass index, waist circumference, waist-hip and waist-height ratio within a meta-analytical framework. In a subset of these individuals, data on genome-wide gene expression level, biomarkers of glucose and lipid metabolism were also available. Validation of methylation markers associated with all adiposity measures was performed in 358 individuals. Finally, we investigated the association of obesity-related methylation marks with breast, colorectal cancer and myocardial infarction within relevant subsets of the discovery population.ResultsWe identified 40 CpG loci with methylation levels associated with at least one adiposity measure. Of these, one CpG locus (cg06500161) in ABCG1 was associated with all four adiposity measures (P = 9.07×10−8 to 3.27×10−18) and lower transcriptional activity of the full-length isoform of ABCG1 (P = 6.00×10−7), higher triglyceride levels (P = 5.37×10−9) and higher triglycerides-to-HDL cholesterol ratio (P = 1.03×10−10). Of the 40 informative and obesity-related CpG loci, two (in IL2RB and FGF18) were significantly associated with colorectal cancer (inversely, P P ConclusionOur results suggest that epigenetic changes, in particular altered DNA methylation patterns, may be an intermediate biomarker at the intersection of obesity and obesity-related diseases, and could offer clues as to underlying biological mechanisms.
- Subjects :
- 0301 basic medicine
Epigenomics
Genetic Markers
Colorectal cancer
Endocrinology, Diabetes and Metabolism
Myocardial Infarction
Medicine (miscellaneous)
Genome-wide association study
macromolecular substances
PERIPHERAL-BLOOD
Bioinformatics
03 medical and health sciences
Endocrinology & Metabolism
0302 clinical medicine
Endocrinology
Neoplasms
medicine
Humans
CPT1A LOCUS
Obesity
Risk factor
11 Medical and Health Sciences
Adiposity
INSULIN-RESISTANCE
Nutrition and Dietetics
business.industry
CHOLESTEROL
Cancer
Epigenome
DNA Methylation
medicine.disease
CANCER
GENE
Diabetes and Metabolism
BODY-MASS INDEX
030104 developmental biology
030220 oncology & carcinogenesis
HIGH-DENSITY-LIPOPROTEINS
Leukocytes, Mononuclear
3-BETA-HYDROXYSTEROID-DELTA-24 REDUCTASE
business
Body mass index
13 Education
Genome-Wide Association Study
Subjects
Details
- Language :
- English
- ISSN :
- 06500161 and 03070565
- Database :
- OpenAIRE
- Journal :
- International Journal of Obesity, 42(12), 2022-2035. Nature Publishing Group, International Journal of Obesity, 42(12), 2022. Nature Publishing Group
- Accession number :
- edsair.doi.dedup.....7812d2b48f50bff4785be72086d11dc5